Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs
- Autores
- Girard Gagnepain, Anais; Amirache, Fouzia; Costa, Caroline; Lévy, Camille; Frecha, Cecilia Ariana; Fusil, Floriane; Nègre, Didier; Lavillette, Dimitri; Cosset, François-Loïc; Verhoeyen, Els
- Año de publicación
- 2014
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Hematopoietic stem cell (HSC)-based gene therapy holds promise for the cure of many diseases. The field is now moving toward the use of lentiviral vectors (LVs) as evidenced by 4 successful clinical trials. These trials used vesicular-stomatitis-virus-G protein (VSV-G)-LVs at high doses combined with strong cytokine-cocktail stimulation to obtain therapeutically relevant transduction levels; however, they might compromise the HSC character. Summarizing all these disadvantages, alternatives to VSV-G-LVs are urgently needed. We generated here high-titer LVs pseudotyped with a baboon retroviral envelope glycoprotein (BaEV-LVs), resistant to human complement. Under mild cytokine prestimulation to preserve the HSC characteristics, a single BaEV-LV application at a low dose, resulted in up to 90% of hCD34+ cell transduction. Even more striking was that these new BaEV-LVs allowed, at low doses, efficient transduction of up to 30% of quiescent hCD34+ cells, whereas high-dose VSV-G-LVs were insufficient. Importantly, reconstitution of NOD/Lt-SCID/γc−/− (NSG) mice with BaEV-LV-transduced hCD34+ cells maintained these high transduction levels in all myeloid and lymphoid lineages, including early progenitors. This transduction pattern was confirmed or even increased in secondary NSG recipient mice. This suggests that BaEV-LVs efficiently transduce true HSCs and could improve HSC-based gene therapy, for which high-level HSC correction is needed for life-long cure.
Fil: Girard Gagnepain, Anais. Université Claude Bernard Lyon 1; Francia
Fil: Amirache, Fouzia. Université Claude Bernard Lyon 1; Francia
Fil: Costa, Caroline. Université Claude Bernard Lyon 1; Francia
Fil: Lévy, Camille. Université Claude Bernard Lyon 1; Francia
Fil: Frecha, Cecilia Ariana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencias; Argentina
Fil: Fusil, Floriane. Université Claude Bernard Lyon 1; Francia
Fil: Nègre, Didier. Université Claude Bernard Lyon 1; Francia
Fil: Lavillette, Dimitri. Centre National de la Recherche Scientifique; Francia
Fil: Cosset, François-Loïc. Université Claude Bernard Lyon 1; Francia
Fil: Verhoeyen, Els. Université Claude Bernard Lyon 1; Francia. Inserm; Francia - Materia
-
Hematopoietic Stem Cells Gene Therapy
Baboon Envelope
Lentiviral Vectors - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/17590
Ver los metadatos del registro completo
id |
CONICETDig_6a0c4aa6915cd8a0bf3d02e5edfc0e35 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/17590 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCsGirard Gagnepain, AnaisAmirache, FouziaCosta, CarolineLévy, CamilleFrecha, Cecilia ArianaFusil, FlorianeNègre, DidierLavillette, DimitriCosset, François-LoïcVerhoeyen, ElsHematopoietic Stem Cells Gene TherapyBaboon EnvelopeLentiviral Vectorshttps://purl.org/becyt/ford/3.4https://purl.org/becyt/ford/3Hematopoietic stem cell (HSC)-based gene therapy holds promise for the cure of many diseases. The field is now moving toward the use of lentiviral vectors (LVs) as evidenced by 4 successful clinical trials. These trials used vesicular-stomatitis-virus-G protein (VSV-G)-LVs at high doses combined with strong cytokine-cocktail stimulation to obtain therapeutically relevant transduction levels; however, they might compromise the HSC character. Summarizing all these disadvantages, alternatives to VSV-G-LVs are urgently needed. We generated here high-titer LVs pseudotyped with a baboon retroviral envelope glycoprotein (BaEV-LVs), resistant to human complement. Under mild cytokine prestimulation to preserve the HSC characteristics, a single BaEV-LV application at a low dose, resulted in up to 90% of hCD34+ cell transduction. Even more striking was that these new BaEV-LVs allowed, at low doses, efficient transduction of up to 30% of quiescent hCD34+ cells, whereas high-dose VSV-G-LVs were insufficient. Importantly, reconstitution of NOD/Lt-SCID/γc−/− (NSG) mice with BaEV-LV-transduced hCD34+ cells maintained these high transduction levels in all myeloid and lymphoid lineages, including early progenitors. This transduction pattern was confirmed or even increased in secondary NSG recipient mice. This suggests that BaEV-LVs efficiently transduce true HSCs and could improve HSC-based gene therapy, for which high-level HSC correction is needed for life-long cure.Fil: Girard Gagnepain, Anais. Université Claude Bernard Lyon 1; FranciaFil: Amirache, Fouzia. Université Claude Bernard Lyon 1; FranciaFil: Costa, Caroline. Université Claude Bernard Lyon 1; FranciaFil: Lévy, Camille. Université Claude Bernard Lyon 1; FranciaFil: Frecha, Cecilia Ariana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencias; ArgentinaFil: Fusil, Floriane. Université Claude Bernard Lyon 1; FranciaFil: Nègre, Didier. Université Claude Bernard Lyon 1; FranciaFil: Lavillette, Dimitri. Centre National de la Recherche Scientifique; FranciaFil: Cosset, François-Loïc. Université Claude Bernard Lyon 1; FranciaFil: Verhoeyen, Els. Université Claude Bernard Lyon 1; Francia. Inserm; FranciaAmerican Society of Hematology2014-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/17590Girard Gagnepain, Anais; Amirache, Fouzia; Costa, Caroline; Lévy, Camille; Frecha, Cecilia Ariana; et al.; Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs; American Society of Hematology; Blood, The Journal Of The American Society Of Hematology - Print; 124; 8; 8-2014; 1221-12310006-4971enginfo:eu-repo/semantics/altIdentifier/url/http://www.bloodjournal.org/content/124/8/1221.long?sso-checked=trueinfo:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2014-02-558163info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:36:45Zoai:ri.conicet.gov.ar:11336/17590instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:36:46.078CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs |
title |
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs |
spellingShingle |
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs Girard Gagnepain, Anais Hematopoietic Stem Cells Gene Therapy Baboon Envelope Lentiviral Vectors |
title_short |
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs |
title_full |
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs |
title_fullStr |
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs |
title_full_unstemmed |
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs |
title_sort |
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs |
dc.creator.none.fl_str_mv |
Girard Gagnepain, Anais Amirache, Fouzia Costa, Caroline Lévy, Camille Frecha, Cecilia Ariana Fusil, Floriane Nègre, Didier Lavillette, Dimitri Cosset, François-Loïc Verhoeyen, Els |
author |
Girard Gagnepain, Anais |
author_facet |
Girard Gagnepain, Anais Amirache, Fouzia Costa, Caroline Lévy, Camille Frecha, Cecilia Ariana Fusil, Floriane Nègre, Didier Lavillette, Dimitri Cosset, François-Loïc Verhoeyen, Els |
author_role |
author |
author2 |
Amirache, Fouzia Costa, Caroline Lévy, Camille Frecha, Cecilia Ariana Fusil, Floriane Nègre, Didier Lavillette, Dimitri Cosset, François-Loïc Verhoeyen, Els |
author2_role |
author author author author author author author author author |
dc.subject.none.fl_str_mv |
Hematopoietic Stem Cells Gene Therapy Baboon Envelope Lentiviral Vectors |
topic |
Hematopoietic Stem Cells Gene Therapy Baboon Envelope Lentiviral Vectors |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.4 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Hematopoietic stem cell (HSC)-based gene therapy holds promise for the cure of many diseases. The field is now moving toward the use of lentiviral vectors (LVs) as evidenced by 4 successful clinical trials. These trials used vesicular-stomatitis-virus-G protein (VSV-G)-LVs at high doses combined with strong cytokine-cocktail stimulation to obtain therapeutically relevant transduction levels; however, they might compromise the HSC character. Summarizing all these disadvantages, alternatives to VSV-G-LVs are urgently needed. We generated here high-titer LVs pseudotyped with a baboon retroviral envelope glycoprotein (BaEV-LVs), resistant to human complement. Under mild cytokine prestimulation to preserve the HSC characteristics, a single BaEV-LV application at a low dose, resulted in up to 90% of hCD34+ cell transduction. Even more striking was that these new BaEV-LVs allowed, at low doses, efficient transduction of up to 30% of quiescent hCD34+ cells, whereas high-dose VSV-G-LVs were insufficient. Importantly, reconstitution of NOD/Lt-SCID/γc−/− (NSG) mice with BaEV-LV-transduced hCD34+ cells maintained these high transduction levels in all myeloid and lymphoid lineages, including early progenitors. This transduction pattern was confirmed or even increased in secondary NSG recipient mice. This suggests that BaEV-LVs efficiently transduce true HSCs and could improve HSC-based gene therapy, for which high-level HSC correction is needed for life-long cure. Fil: Girard Gagnepain, Anais. Université Claude Bernard Lyon 1; Francia Fil: Amirache, Fouzia. Université Claude Bernard Lyon 1; Francia Fil: Costa, Caroline. Université Claude Bernard Lyon 1; Francia Fil: Lévy, Camille. Université Claude Bernard Lyon 1; Francia Fil: Frecha, Cecilia Ariana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencias; Argentina Fil: Fusil, Floriane. Université Claude Bernard Lyon 1; Francia Fil: Nègre, Didier. Université Claude Bernard Lyon 1; Francia Fil: Lavillette, Dimitri. Centre National de la Recherche Scientifique; Francia Fil: Cosset, François-Loïc. Université Claude Bernard Lyon 1; Francia Fil: Verhoeyen, Els. Université Claude Bernard Lyon 1; Francia. Inserm; Francia |
description |
Hematopoietic stem cell (HSC)-based gene therapy holds promise for the cure of many diseases. The field is now moving toward the use of lentiviral vectors (LVs) as evidenced by 4 successful clinical trials. These trials used vesicular-stomatitis-virus-G protein (VSV-G)-LVs at high doses combined with strong cytokine-cocktail stimulation to obtain therapeutically relevant transduction levels; however, they might compromise the HSC character. Summarizing all these disadvantages, alternatives to VSV-G-LVs are urgently needed. We generated here high-titer LVs pseudotyped with a baboon retroviral envelope glycoprotein (BaEV-LVs), resistant to human complement. Under mild cytokine prestimulation to preserve the HSC characteristics, a single BaEV-LV application at a low dose, resulted in up to 90% of hCD34+ cell transduction. Even more striking was that these new BaEV-LVs allowed, at low doses, efficient transduction of up to 30% of quiescent hCD34+ cells, whereas high-dose VSV-G-LVs were insufficient. Importantly, reconstitution of NOD/Lt-SCID/γc−/− (NSG) mice with BaEV-LV-transduced hCD34+ cells maintained these high transduction levels in all myeloid and lymphoid lineages, including early progenitors. This transduction pattern was confirmed or even increased in secondary NSG recipient mice. This suggests that BaEV-LVs efficiently transduce true HSCs and could improve HSC-based gene therapy, for which high-level HSC correction is needed for life-long cure. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-08 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/17590 Girard Gagnepain, Anais; Amirache, Fouzia; Costa, Caroline; Lévy, Camille; Frecha, Cecilia Ariana; et al.; Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs; American Society of Hematology; Blood, The Journal Of The American Society Of Hematology - Print; 124; 8; 8-2014; 1221-1231 0006-4971 |
url |
http://hdl.handle.net/11336/17590 |
identifier_str_mv |
Girard Gagnepain, Anais; Amirache, Fouzia; Costa, Caroline; Lévy, Camille; Frecha, Cecilia Ariana; et al.; Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs; American Society of Hematology; Blood, The Journal Of The American Society Of Hematology - Print; 124; 8; 8-2014; 1221-1231 0006-4971 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://www.bloodjournal.org/content/124/8/1221.long?sso-checked=true info:eu-repo/semantics/altIdentifier/doi/10.1182/blood-2014-02-558163 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
American Society of Hematology |
publisher.none.fl_str_mv |
American Society of Hematology |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613155420897280 |
score |
13.070432 |